Stephanie Mok, PhD, Pmp
About Stephanie Mok, PhD, Pmp
Stephanie Mok, PhD, PMP, serves as the Associate Director of Program Management at Alpine Immune Sciences, Inc., where she leads clinical program execution and collaborates with various departments. With a strong background in biopharmaceutical development and strategic program planning, she has held multiple roles in healthcare and research organizations over her career.
Work at Alpine Immune Sciences
Stephanie Mok serves as the Associate Director of Program Management at Alpine Immune Sciences, Inc. since 2022. In this role, she leads the program execution for the company's lead clinical program. She collaborates with cross-functional teams, including regulatory affairs, CMC, biostatistics, and clinical development, to ensure effective program management. Her focus on strategic program planning and portfolio management contributes to the overall success of the organization.
Education and Expertise
Stephanie Mok holds a Doctor of Philosophy (Ph.D.) in Neuroscience from the University of Cambridge. She also earned an A.B. in Neurobiology and Global Health Policy from Harvard University. Her educational background supports her expertise in product development and lifecycle management of therapeutic assets, particularly in the biopharmaceutical sector. She specializes in the development of therapies from preclinical stages through late-stage clinical development.
Background
Stephanie Mok has a diverse professional background in program management and policy analysis. Prior to her current role, she worked at Quantum Leap Healthcare Collaborative as a Senior Collaborations Manager in Business Development. She also held positions at Zymeworks Inc. and the Allen Institute for Brain Science, where she managed projects and alliances. Her earlier experience includes roles at the National Institute of Mental Health and the National Institutes of Health, where she focused on health science policy.
Achievements
Throughout her career, Stephanie Mok has developed a multidisciplinary background that encompasses scientific research, data generation, clinical operations, and health and science policy. She has direct experience in biopharmaceutical development, particularly in oncology and autoimmune diseases. Her contributions to program management and strategic planning have been instrumental in advancing clinical programs and fostering collaboration across various departments.